These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7794654)

  • 1. A comparative study on the efficacy of a mass screening program for colorectal cancer--comparison between cancer cases detected by mass screening and by outpatient clinics.
    Nakama H
    Asia Pac J Public Health; 1994; 7(3):159-64. PubMed ID: 7794654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of effectiveness of mass screening for colorectal cancer.
    Fujita M; Sugiyama R; Kumanishi Y; Ota J; Horino T; Nakano Y; Taguchi T
    World J Surg; 1990; 14(5):648-52; discussion 652-3. PubMed ID: 2238667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening.
    Zhang B; Fattah A; Nakama H
    Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression rates of colorectal cancer by Dukes' stage in a high-risk group: analysis of selective colorectal cancer screening.
    Wong JM; Yen MF; Lai MS; Duffy SW; Smith RA; Chen TH
    Cancer J; 2004; 10(3):160-9. PubMed ID: 15285925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan.
    Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C
    Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of colorectal carcinomas detected by mass screening].
    Kikkawa N; Tsuchiya Y; Matsui S; Murai M; Yamamoto H; Matsui K
    Gan No Rinsho; 1989 Jul; 35(8):923-6. PubMed ID: 2746866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Health Service Bowel Cancer Screening Program: the early years.
    Rees CJ; Bevan R
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):421-37. PubMed ID: 23899282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
    Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
    Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.
    McClements PL; Madurasinghe V; Thomson CS; Fraser CG; Carey FA; Steele RJ; Lawrence G; Brewster DH
    Cancer Epidemiol; 2012 Aug; 36(4):e232-42. PubMed ID: 22425027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
    Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
    Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study.
    Nakama H; Kamijo N; Abdul Fattah AS; Zhang B
    J Med Screen; 1996; 3(2):63-5. PubMed ID: 8849761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of colorectal cancer stage among HMO members targeted for screening.
    Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
    Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Ann Nucl Med; 2014 Apr; 28(3):212-9. PubMed ID: 24347363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass screening for colorectal cancer in Japan.
    Hisamichi S; Fukao A; Fujii Y; Tsuji I; Komatsu S; Inawashiro H; Tsubono Y
    Cancer Detect Prev; 1991; 15(5):351-6. PubMed ID: 1751945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
    Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
    Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.